Thanks to the robust and diverse pipeline, by 2030, AbbVie is expected to have more than 30 new products or indications approved in China, covering immunology, solid tumour, blood cancer eye care, neuroscience and aesthetics.
SHINE
Mental Health: A new National Institute of Mental Health and Neurosciences (NIMHANS-2) will be set up in North India to bridge the regional gap in tertiary mental healthcare.
PMF IAS
With a massive pipeline in neuroscience, specifically Alzheimer's treatments, many analysts predict they will climb several spots in the pharmaceutical industry rankings by 2030.
Global Healthcare Magazine
As the experts in brain health, neurologists will ask lawmakers to maintain strong federal support for neuroscience research, including the National Institutes of Health Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative.
EurekAlert!
The pipeline breadth is impressive - 19 NMEs by 2030 spanning oncology, neuroscience, cardiometabolic, immunology, and gene therapy.
SyneticX
Neuralink could redefine what's possible within neuroscience, but with innovation must come introspection.
The Pinnacle Gazette
Pure-play psychedelic developers offer asymmetric upside tied to discrete clinical and regulatory inflection points, while larger neuroscience companies provide a more measured way to participate in innovation with lower binary risk.
Gainify
Regulatory scrutiny will remain elevated across immunology, neuroscience and aesthetics as AbbVie expands its pipeline and category exposure.
Gainify
AbbVie announced it broke ground on a $195 million state-of-the-art active pharmaceutical ingredient (API) facility that will manufacture immunology, oncology and neuroscience medicines. / USA
Cision PR Newswire
Last updated: 16 June 2026
Hi,
Would you like a quick online demo of our service from an experienced member of our team?
